Temasek Holdings

Temasek Holdings, established in 1974 and based in Singapore, is an investment company managing a diversified portfolio valued at approximately S$242 billion. The firm actively invests across various sectors, including telecommunications, media and technology, financial services, transportation, consumer products, real estate, life sciences, and energy. Temasek focuses on long-term investment themes such as transforming economies, growing middle-income populations, deepening comparative advantages, and supporting emerging champions. Its investment strategy encompasses a combination of liquid assets, listed and unlisted equities, and private equity opportunities, with a notable emphasis on mid-stage technology and life sciences investments through its private equity arm, Temasek Capital Management. Furthermore, Temasek aims to be the preferred investor for companies in Singapore and internationally, reflecting its commitment to global investment opportunities.

Pradyumna Agrawal

Director

Soyoun Ahn

Managing Director, Investment (Credit and Hybrid Solutions)

Gary Ang

Managing Director, Macro Strategy

Parimal Aswani

Managing Director, Technology

Ravi Balasubramanian

Managing Director, Portfolio Development, New Energy and Industrials

Siddartha Bhattacharjee

Head of Mobility and Logistics and Managing Director of Portfolio Strategy & Risk Group

Eric Bielke

Director

Wendy Chandra

Managing Director, Technology

Yuliang Chang

Managing Director, Investment (China)

Eu Chua

Managing Director, Institutional Relations and Singapore Market

Ranjit Dandekar

Managing Director, Investment

Promit Ghosh

Managing Director

Reena Kanagasingam

Managing Director, Investment (Public Markets)

Ming Pey Lim

Chief of Staff, Executive Office, Deputy Chief Corporate Officer and Managing Director, Strategy Office

Sheau Ming Lim

Director

Paul Liu

Managing Director, Investment (Financial Services), Portfolio Strategy and Risk Group

Anuj Maheshwari

Head, Agri-Food Managing Director, Investment (Middle East and Africa)

Nicolas Meier

Managing Director, Investment (EMEA) and Director

Jingwen Miao

Managing Director, Investment (China)

Suranjan Mukherjee

Managing Director, Cross Asset Macro Portfolio and Joint Head, Public Market Investment Strategies

Jonathan Popper

Managing Director, Portfolio Development Group

Ryan Rakestraw

Director

Parangam Ray

Managing Director, Organisation and People

Pierce Scranton

Managing Director, Institutional Relations and Deputy Head, North America

Shaun Seow

Managing Director, Singapore Market and Head, Community Stewardship

Rohit Sobti

Managing Director, New Energy and Industrials

Jason Sun

Chief Representative, Beijing and Managing Director, Investment (China)

Belinda Tan

Managing Director, Finance (Financial Management)

Man-Keung Tang

Managing Director, Macro Strategy

Sulian Tay

Operating Partner

Alan Thompson

Operating Partner

Karen Toh

Managing Director, Finance (Treasury)

Damien Vacherot

Director

Benoit Valentin

Senior Managing Director EMEA and Head of Private Equity Fund Investments

Rob Williams

Managing Director, Investment (EMEA)

Ye Xu

Managing Director, Investment (China)

Past deals in Series C

Foretellix

Series C in 2023
Foretellix Ltd. specializes in developing a verification framework for Intelligent Autonomous Systems, with a primary focus on Autonomous Vehicles. Founded in 2010 and based in Tel Aviv, Israel, the company provides solutions for inspecting and verifying the safety of complex automated driving systems. Foretellix has created a unique language that serves as a standard for describing scenarios related to autonomous vehicle operation. By employing a Coverage Driven Verification methodology, which has been successfully utilized in the semiconductor industry, Foretellix aims to enhance the safety verification and validation processes for Advanced Driver Assistance Systems (ADAS) and autonomous vehicles. The company's innovative approach aims to reduce risks, costs, and time to market in the rapidly evolving field of automotive technology.

UPSIDE Foods

Series C in 2022
UPSIDE Foods, formerly known as Memphis Meats, is a company headquartered in San Francisco, California, that specializes in producing cultured meat directly from animal cells. Founded in 2015 by Uma Valeti and Nicholas Genovese, the company focuses on developing products such as hot dogs, sausages, burgers, and meatballs without the need to raise and slaughter animals. This innovative approach to meat production requires significantly less caloric input, water, land, and energy compared to traditional methods, while also aiming to provide consumers with cleaner meat products that are free from harmful chemicals.

Autobrains

Series C in 2022
Cartica’s revolutionary automotive visual intelligence platform is built on the foundation of a mature self-learning technology backed by more than 200 patents. Utilizing robust signature-based representation structures coupled with unsupervised learning methodologies, Cartica’s visual intelligence platform garners a comprehensive and detailed understanding of the vehicle’s environment.

Immutable

Series C in 2022
Immutable Pty Ltd, founded in 2018 and based in Sydney, Australia, specializes in developing video games that leverage blockchain technology. The company focuses on creating scalable infrastructure that enhances in-game economies, promoting transparency and enabling player ownership of in-game assets. Immutable provides tools and services that allow players the freedom to trade and build their gaming experiences. Originally known as Fuel Games Pty Ltd, the company emphasizes empowering players by returning control over digital assets to them.

FTX

Series C in 2022
FTX Trading LTD is a cryptocurrency derivatives exchange founded in 2017 and based in San Francisco, California. The platform caters to both professional traders and novices, offering features such as futures trading, leveraged tokens, and an over-the-counter portal. It supports a variety of financial products, including quarterly and perpetual futures for major cryptocurrencies like bitcoin, ether, and binance coin, as well as various altcoin and midcap indices. FTX was co-founded by Sam Bankman-Fried and Gary Wang, with initial backing from Alameda Research, which provided significant liquidity from the outset. The exchange aims to enhance the cryptocurrency trading experience and facilitate institutional adoption within the sector.

eFishery

Series C in 2022
eFishery is automatic fish feeder for all types of fish. This tool can not only provide feed scheduled, with a dose efficient, and automatic, but also record every feed in real-time. You can access the data feed, anytime, anywhere with precision. There is no longer a problem of over-feeding, fish feeding or feed irregularly diverted. eFishery provide the best solutions, reliable, and affordable.

Ola Electric

Series C in 2021
Ola Electric Mobility Pvt Limited, founded in 2017 and headquartered in Bengaluru, India, is a prominent player in the electric vehicle sector. As a subsidiary of ANI Technologies Private Limited, the company specializes in the manufacturing of electric vehicles and key components, such as battery packs, motors, and vehicle frames, at its Ola Futurefactory. Ola Electric aims to enhance electric mobility by collaborating with vehicle and battery manufacturers, cities, and driver-partners to create a comprehensive and affordable mobility ecosystem. The company not only focuses on the domestic market but is also exploring opportunities for exporting its electric vehicles to select international markets, positioning itself to capitalize on the growing demand for sustainable transportation solutions in India and beyond.

Clara Foods Co.

Series C in 2021
Clara Foods Co. specializes in producing animal-free proteins and ingredients for the food and beverage industry. Founded in 2014 and based in South San Francisco, California, the company utilizes advanced fermentation techniques to create functional and nutritional proteins derived from microorganisms. This innovative approach allows Clara Foods to offer a sustainable alternative to traditional animal agriculture, focusing on products such as baking ingredients, nutritional supplements, and egg white substitutes that are free from pathogens and salmonella. Their egg white products are particularly suited for baking applications, including cakes, meringues, and macarons. Clara Foods aims to transform the food industry by providing healthier and more humane protein sources.

Carro

Series C in 2021
Carro is an automotive marketplace that offers a full-stack service for all aspects of car ownership. It challenges the traditional way of buying and selling of cars through a proprietary pricing algorithm. Carro also provides a range of services that offer everything a car owner needs throughout their car ownership journeys such as an in-house financing solution warranty options and Singapore’s first on-demand roadside recovery platform. The company was founded in 2015 and is headquartered in Singapore.

Edge Medical Robotics

Series C in 2021
Edge Medical Robotics, Inc. is a company that specializes in designing and developing advanced surgical equipment. Founded on May 4, 2017, and based in Longgang, Shenzhen, China, the company is dedicated to researching and promoting cutting-edge medical technology. Its mission focuses on enhancing surgical safety and treatment efficacy, aiming to elevate the overall standards of healthcare. Through a commitment to excellence and precision in product development, Edge Medical Robotics strives to contribute positively to the improvement of social health outcomes.

Autobrains

Series C in 2021
Cartica’s revolutionary automotive visual intelligence platform is built on the foundation of a mature self-learning technology backed by more than 200 patents. Utilizing robust signature-based representation structures coupled with unsupervised learning methodologies, Cartica’s visual intelligence platform garners a comprehensive and detailed understanding of the vehicle’s environment.

Autobrains

Series C in 2021
Cartica’s revolutionary automotive visual intelligence platform is built on the foundation of a mature self-learning technology backed by more than 200 patents. Utilizing robust signature-based representation structures coupled with unsupervised learning methodologies, Cartica’s visual intelligence platform garners a comprehensive and detailed understanding of the vehicle’s environment.

Memed

Series C in 2021
Memed SA, founded in 2012 and based in Brazil, operates an online platform that provides e-prescription services and social collaboration tools for healthcare professionals. The platform enables doctors to create and manage digital prescriptions, facilitating effective treatment and improving patient adherence to prescribed medications. By connecting healthcare providers with key partners in the industry, Memed enhances the prescription process and supports communication among doctors, ultimately aiming to improve patient care and outcomes.

Fabric

Series C in 2021
Fabric is developing an on-demand supply chain solution aimed at grocery retailers, enabling them to provide sustainable, one-hour delivery services to their online customers. The company has created Micro-Fulfillment Centers, which are urban, automated fulfillment facilities designed to optimize local distribution while maintaining cost-efficiency. By leveraging advanced robotics and artificial intelligence, Fabric redefines the fulfillment and delivery process in urban settings. This innovative approach addresses the challenges of last-mile delivery, allowing retailers to implement true on-demand services, significantly lower operational costs, and achieve enhanced scalability in their operations.

Orca Security

Series C in 2021
Orca Security Ltd. is a company that specializes in cloud-native security solutions, providing a platform that secures both cloud-native and legacy applications migrated to the cloud. Founded in 2019 and based in Tel Aviv, Israel, Orca's technology integrates directly into the cloud infrastructure layer, allowing for comprehensive security assessments of various assets, including the cloud control plane, operating systems, applications, and business data. The platform delivers visibility into compromised resources, vulnerable software, and misconfigurations without the need for agents, thus maintaining performance and availability. By offering cloud-wide, workload-deep security and compliance across major cloud providers like AWS, Azure, and Google Cloud, Orca Security helps organizations identify critical vulnerabilities and attack vectors efficiently, minimizing the operational costs and alert fatigue associated with traditional security tools.

Momenta

Corporate Round in 2021
Momenta is an autonomous driving startup operating out of Beijing. Its deep-learning based software in perception, HD semantic mapping, and data-driven path planning enables the realization of full autonomy. Momenta offers multi-level autonomous driving solutions as well as big data products and services. Momenta’s team is composed of some of the world’s top experts in computer vision and deep learning, including one of the authors of Faster R-CNN and ResNet, the most popular deep learning network, as well as winners of ImageNet 2015, MS COCO Challenge 2015, and ImageNet 2017. Momenta is leading the autonomous driving software space with advanced technical competence and a strong commitment to innovation.

Allay Therapeutics

Series C in 2021
Allay Therapeutics offers analgesic products for post-surgical pain management and recuperation. The company was founded in 2017 and is headquartered in Menlo Park, California, United States.

Solugen

Series C in 2021
Solugen, Inc. is a specialty chemicals manufacturer based in Houston, Texas, founded in 2016. The company utilizes industrial biotechnology and green chemistry to produce a range of eco-friendly industrial chemicals. Its product offerings include BioPeroxide, a carbon-negative hydrogen peroxide; BioChelate, a biodegradable chelant; ScavSol, a multivalent metal sequestrant for energy applications; ScaleSol, a scale control alternative to phosphonates; and CorrSol, designed for corrosion and fouling control. Solugen focuses on creating safe, cost-effective, and environmentally-friendly solutions, serving various sectors such as agriculture, cleaning, energy, and water. The company employs a patented method that leverages bio-inspired reactions and plant materials as low-cost feedstocks, enabling it to produce innovative products that are competitively priced in the market.
Open develops and offers an online platform for banking and intercompany settlement. It offers digital banking service for startups and small and medium enterprises that offer digital bank accounts that includes a current account packed with tools for bookkeeping, invoices, moving money, and accessing credit. Open's application programming interface platform lets financial institutions integrate banking and payments into their applications and accounting systems. Anish Achuthan founded it in 2017, with its headquarters in Bengaluru in India.

Solugen

Series C in 2021
Solugen, Inc. is a specialty chemicals manufacturer based in Houston, Texas, founded in 2016. The company utilizes industrial biotechnology and green chemistry to produce a range of eco-friendly industrial chemicals. Its product offerings include BioPeroxide, a carbon-negative hydrogen peroxide; BioChelate, a biodegradable chelant; ScavSol, a multivalent metal sequestrant for energy applications; ScaleSol, a scale control alternative to phosphonates; and CorrSol, designed for corrosion and fouling control. Solugen focuses on creating safe, cost-effective, and environmentally-friendly solutions, serving various sectors such as agriculture, cleaning, energy, and water. The company employs a patented method that leverages bio-inspired reactions and plant materials as low-cost feedstocks, enabling it to produce innovative products that are competitively priced in the market.

Oviva

Series C in 2021
Oviva is a digital health company providing medically-oriented nutritional counseling services in Switzerland, Germany, and the United Kingdom. Founded in 2013 and headquartered in Ingenbohl, Switzerland, Oviva offers personalized behavior change programs aimed at managing diet and lifestyle-related health issues like obesity and diabetes. Their services are delivered through a network of qualified dietitians who work with clients both in clinics and remotely. The company has developed a smartphone application that allows users to engage with their dietitian, maintain a food diary, set health goals, and access tailored educational materials. This technology-enabled approach helps patients achieve better health outcomes while reducing the need for in-person appointments, ultimately lowering healthcare costs by preventing complications associated with these conditions.

Abogen Biosciences

Series C in 2021
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.

Covariant

Series C in 2021
Covariant is a company focused on developing artificial intelligence for robotics. It is creating the Covariant Brain, a universal AI system that enables robots to perceive, reason, and interact with their environments. The company specializes in robotics software that utilizes deep imitation learning, deep reinforcement learning, and meta-learning techniques. This innovative approach allows clients to program robots with ease by using a virtual reality headset to guide them through specific tasks. Covariant aims to streamline the deployment of robotics across various operations, enhancing efficiency and adaptability in industrial settings.

iCapital Network

Series C in 2021
iCapital Network is an online platform that unlatches the world of private equity, enabling institutions and qualified investors. It is a financial services company that features a financial technology platform that provides modular alternative investment solutions for registered investment advisors, broker-dealers, private banks, family offices, and other sophisticated investors. The company connects advisors and their high net worth investors in leading alternative investment managers through best-in-class user experience. The company was founded in 2013 and headquartered in New York, United States.

Soldo

Series C in 2021
Soldo Limited is a provider of expense management software solutions tailored for small businesses, enterprises, and accountants. Established in 2014 and based in London, with additional offices in Italy and Ireland, Soldo offers various products, including Soldo Pro, which manages expenses from payment to reconciliation, Soldo Premium for controlling business spending, and Soldo Enterprise for supporting financial strategies. The platform integrates prepaid Mastercard® cards, a web-based administration console, and a mobile app, offering a comprehensive solution to streamline the business expense cycle. This system enhances visibility and control over company spending while automating tasks and ensuring compatibility with major accounting software. Soldo has garnered significant investment, exceeding $80 million, from notable investors, reflecting its commitment to innovation in the fragmented landscape of business spending management.

Orient Speech Therapy

Series C in 2021
Provider of speech and language therapy services intended for stunted children with speech disorder. The company provides early screening, clinical diagnosis, and therapeutic interventions to children with autism or speech disorder, enabling children to speak and communicate better.

RecBio

Series C in 2021
Jiangsu Recbio Technology Co Ltd is a vaccine company dedicated to the development and commercialization of safer and more effective vaccines to address the far-unmet public needs. Hygiene needs. The company focuses on the R&D of HPV vaccine candidates. The company's vaccine portfolio currently consists of 12 vaccines, including three strategic products, namely REC603, a recombinant HPV 9-valent vaccine under phase III clinical trial.

Helix

Series C in 2021
Helix is a prominent population genomics company that operates at the intersection of clinical care, research, and data analytics. The company provides an end-to-end platform designed to facilitate genomic research and the incorporation of genomic data into healthcare practices. Helix operates one of the largest CLIA/CAP-certified next-generation sequencing laboratories and utilizes its proprietary Exome+™ assay to support various aspects of population genomics. These include recruitment and engagement, clinically actionable disease screening, and the return of results. Additionally, Helix engages in large-scale genetic analysis and viral surveillance, delivering actionable genetic insights that aid health systems, life sciences companies, payers, and government entities in enhancing patient care and informing public health decisions.

Bowery

Series C in 2021
Bowery Farming Inc. is a modern agricultural company based in New York City, specializing in the cultivation of post-organic produce such as baby kale, lettuce, arugula, and basil. Founded in 2014, Bowery employs advanced technology, including its proprietary BoweryOS software, to create optimal growing conditions in indoor farms. This system utilizes automation, machine learning, and vision systems to monitor plant growth continuously, resulting in highly efficient farming practices. Bowery's operations use zero pesticides and consume 95% less water while achieving over 100 times the productivity of traditional farming methods on the same land area. The company sells its products through grocery stores, including select Whole Foods and Foragers locations, and supplies produce to various restaurants, including those owned by renowned chef Tom Colicchio. Bowery Farming is committed to transforming agriculture to ensure a sustainable and healthier food supply for the future.

Oura

Series C in 2021
Oura is a pioneering sleep performance platform, focused on improving sleep that leads to a better life. The Oura Ring and app gives users daily feedback to improve their health, allowing users to better understand their body and reach their goals. Oura Health OyLtd. is a health technology company founded in Oulu, Finland in 2013. In 2018, the company received the Red Dot Awards for communications design and product design. Backed by world-class investors, leaders, champions, and creators, Oura Health is based in Oulu & Helsinki, Finland, and San Francisco, California.

Abiochem Biotechnology

Series C in 2021
Abiochem Biotechnology is a high-tech enterprise specializing in enzyme engineering and genetic engineering technologies. The company focuses on researching and developing biocatalytic and synthetic biology methods, which are applied to large-scale production across various sectors. Its innovations are utilized in pharmaceuticals, health care products, and pesticides, contributing to advancements in green chemistry. Abiochem Biotechnology offers customized genetic and enzyme engineering services, positioning itself as a provider of bio-intelligent manufacturing solutions for chemical and biological products.

EAVISION

Series C in 2021
EAVISION is a smart hardware company that specializes in the development and manufacturing of autonomous drones for agricultural applications. Their products incorporate advanced technologies such as artificial intelligence, autonomous driving, and machine vision, allowing for fully automated processes in plant protection, including pesticide spraying and fertilization. In addition to agricultural drones, EAVISION also offers binocular visual perception systems, AI-driven autonomous control solutions, intelligent machinery, software, and a commercial corn emasculation testing system. Through these innovations, EAVISION aims to enhance the efficiency and safety of agricultural operations. The company is also associated with a venture capital fund, focusing on investments in China.

Halodoc

Series C in 2021
PT HaloDoc is a digital healthcare platform based in Jakarta, Indonesia, founded in 2016. It connects patients with a network of 19,000 licensed doctors and 1,000 certified partner pharmacies through its services. Users can engage with medical professionals via video calls, voice calls, and chat, facilitating real-time online consultations. The platform also allows patients to order laboratory tests that can be conducted at home and helps them locate nearby hospitals and clinics. Additionally, HaloDoc provides access to licensed medical laboratory services and a medical delivery service known as ApotikAntar, further enhancing the convenience and accessibility of healthcare for its users.

Hazel Technologies

Series C in 2021
Hazel Technologies, Inc. designs and manufactures packaging inserts to reduce the spoilage of fruits and vegetables. It offers packaging inserts called sachets that are placed in boxes of the produce by growers at the time of harvest, extending the shelf-life of produce by slowing aging in produce and preventing fungus or decay. The company also provides agricultural and horticultural consulting services. Hazel Technologies, Inc. was founded in 2015 and is based in Chicago, Illinois with an additional location in Salinas, California.

Genki Forest

Venture Round in 2021
Genki Forest is a beverage company with Internet genes which specializes in making sugar-free and low-calorie products.

NewMed Medical

Series C in 2021
NewMed Medical Co., Ltd. is a Shanghai-based company focused on the research, development, manufacture, and marketing of interventional artificial heart valve systems. Established in 2015, the company specializes in producing artificial heart valves and transcather implantation systems designed to replace diseased mitral valves. These innovative products aim to simplify heart valve replacement surgery, thereby reducing treatment risks and facilitating quicker patient recovery while also lowering surgical costs. Through its advancements in medical technology, NewMed Medical contributes to improved outcomes in cardiac care.

Tezign

Series C in 2021
Tezign (Beijing) Information Technology Co., Ltd. operates Tezign.com, an Internet platform in China that provides design, creativity, marketing, and experience need services. It offers market and design services, including web/app design, graphic design, illustration, photography, creative strategy, brand strategy, e-commerce solution, event planning, and AR and VR. Tezign (Beijing) Information Technology Co., Ltd. was founded in 2014 and is based in Shanghai, China.

insitro

Series C in 2021
Insitro, Inc. is a data-driven drug discovery and development company based in South San Francisco, California, founded in 2018. The company utilizes machine learning and high-throughput biology to transform the traditional processes of drug discovery and delivery. By generating extensive functional genomic datasets and aligning them with patient data through innovative machine learning techniques, Insitro builds predictive models that aim to address critical challenges in pharmaceutical research and development. These models facilitate accelerated target selection and the design of effective therapeutics, ultimately enhancing the efficiency of drug development and informing clinical strategies. The focus of Insitro's work includes the treatment of nonalcoholic steatohepatitis (NASH), showcasing its commitment to addressing significant health issues through advanced technology.

Clover Biopharmaceuticals

Series C in 2021
Clover Biopharmaceuticals is a clinical-stage biotechnology company based in Chengdu, China, focused on discovering and developing innovative biologic therapies for cancer, autoimmune diseases, and infectious diseases. Founded in 2007, the company utilizes its proprietary Trimer-Tag technology platform to create novel biologics that target trimerization-dependent pathways. Clover also offers integrated biopharmaceutical drug manufacturing services and has in-house capabilities for cGMP biomanufacturing, which support the development of select biosimilars. Through its research and development efforts, Clover aims to bring transformative therapies to the market.

Black Lake Technologies

Series C in 2021
Black Lake Technologies is an innovative company focused on transforming manufacturing through advanced mobile, IoT, and web-based collaboration platforms. These platforms enable real-time data acquisition, visualization, monitoring, and analysis, facilitating seamless communication among factory staff, from management to assembly line workers. By providing algorithm-driven and easily configurable systems, Black Lake lowers the barriers for manufacturers to adopt data analytics, fostering self-innovation and enhancing operational efficiency. The company serves a diverse clientele, including medium-sized enterprises and Fortune 500 companies, streamlining their production processes. With significant venture backing and over CNY 100 million in funding, Black Lake is well-positioned to lead the evolution of smart factories and improve manufacturing cycles.

Provivi

Series C in 2020
Provivi Inc. develops biopesticides for agriculture, commercial, household, and public health pest management. It develops research quantities of carbene/nitrene transferase enzymes that activate diazo and azide compounds to generate iron-carbenoids and iron-nitrenoids through a mode of activation. The company also develops a biocatalysis and fermentation technology, which is based on biocatalysts that enable efficient synthesis of biopesticides. Its technology has applications in industries, such as pharmaceuticals, nutrition, flavors, and fragrances. The company offers its products through distributors worldwide. Provivi Inc. was incorporated in 2012 and is based in Santa Monica, California.

Form Energy

Series C in 2020
Form Energy, Inc. specializes in developing long-duration energy storage systems aimed at facilitating the transition from fossil fuels to renewable energy sources. The company focuses on creating low-cost battery solutions capable of storing electricity generated from wind and solar power for extended periods, thereby enhancing the reliability of the electric grid. Its core technology, which includes an innovative iron-air battery, allows for energy dispatch over multiple days, significantly improving the viability of renewable energy as a consistent power source. Founded in 2017 and headquartered in Somerville, Massachusetts, Form Energy also offers Formware, a software tool designed for capacity expansion with advanced optimization capabilities. The company's mission revolves around enabling deep decarbonization of the electric system, ultimately contributing to a more sustainable energy future. Form Energy has garnered support from various investors, including Breakthrough Energy Ventures and MIT’s The Engine.

Gracell

Series C in 2020
Gracell Biotechnologies Inc. is a clinical-stage biopharmaceutical company based in Shanghai, China, focused on discovering and developing innovative cell therapies for cancer treatment. The company's lead product candidates include GC012F, a dual-targeted CAR-T therapy for multiple myeloma currently in Phase I trials; GC019F, which targets adult B cell acute lymphoblastic leukemia and is also in Phase I trials; and GC007F, aimed at B cell non-Hodgkin’s lymphoma, also in Phase I. Additionally, Gracell is developing GC027, a CAR-T candidate targeting adult T cell acute lymphoblastic leukemia, and GC007g, an allogeneic CAR-T therapy for relapsed or refractory B-ALL, both in Phase I trials. Beyond these, Gracell has a pipeline of earlier-stage product candidates targeting various cancers, including ovarian and breast cancer. Founded in 2017, Gracell Biotechnologies is committed to advancing cellular therapeutics to improve patient outcomes in hematological malignancies and solid tumors.

TrueLayer

Series C in 2020
TrueLayer Limited is a London-based company that offers a platform for building financial applications. Established in 2016, it provides a toolkit designed to connect to bank data, verify accounts, and access transactions in real-time. TrueLayer's software-as-a-service (SaaS) platform enables the development of various consumer and small-to-medium business applications in sectors such as payments, online lending, personal financial management, robot-advisors, insurance, investment services, peer-to-peer marketplaces, and cryptocurrencies. The company's solutions are utilized by fintech startups, online lenders, and personal finance managers, contributing to the growth of the open banking economy by facilitating the creation of innovative financial services and products.

BlueVoyant

Series C in 2020
BlueVoyant is a cybersecurity company founded in 2017 and headquartered in New York, NY. It specializes in cybersecurity defense and protection by providing a blend of technology and tailored services. The company offers advanced cyber threat intelligence and managed security services, along with proactive professional services that include forensic capabilities for incident response and remediation. BlueVoyant caters to large enterprises by delivering impactful intelligence while also making its comprehensive software and services accessible to small and medium enterprises. By leveraging a world-class team of experts, BlueVoyant enhances visibility, professional insights, and targeted responsiveness in the realm of cybersecurity, ensuring robust protective measures for its clients.

Perfect Day

Series C in 2020
Perfect Day, Inc. is a company that specializes in producing animal-free dairy products, including milk, cheese, yogurt, and ice creams. Founded in 2014 and headquartered in Emeryville, California, the company utilizes yeast fermentation of plant-based sugars to create dairy proteins that are nutritionally identical to those found in cow's milk. This innovative approach allows Perfect Day to offer products that replicate the taste, texture, and nutritional benefits of traditional dairy while avoiding the environmental and ethical concerns associated with animal agriculture. The company's offerings are sustainable, vegan, and free from antibiotics, cholesterol, and lactose, catering to consumers seeking healthier and more compassionate alternatives to conventional dairy.

Arterys

Series C in 2020
Arterys Inc. is a technology company specializing in medical imaging analytics, aiming to enhance patient care through innovative solutions. Founded in 2007 and headquartered in San Francisco, California, with additional offices in Calgary and Paris, Arterys offers a cloud-based, AI-powered platform that enables radiologists to visualize and quantify blood flow in the body. Its product lineup includes Cardio AI for cardiac imaging, Lung AI for lung analysis, Liver AI for liver diagnostics, and Chest/MSK AI for detecting various thoracic and musculoskeletal conditions. The platform is fully web-based and FDA-cleared, providing clinicians with tools for automatic and interactive reporting. Additionally, the Arterys PHI Service allows physicians to access patient data remotely, further supporting efficient medical practices.

Pivot Bio

Series C in 2020
Pivot Bio is a biotechnology company founded in 2010 and based in Emeryville, California, that focuses on enhancing crop nutrition through the use of engineered microbes. The company leverages its deep understanding of the plant microbiome, employing engineering principles and data science to map microbial dynamics and develop beneficial traits. Pivot Bio's proprietary ON Technology utilizes naturally occurring microbes to provide crops with essential nutrients, particularly nitrogen, which is crucial for growth. This innovative approach aims to replace synthetic nitrogen fertilizers, thereby reducing the environmental impact associated with conventional farming practices. By enhancing crops' ability to capture and metabolize atmospheric nitrogen, Pivot Bio seeks to lower farming costs, improve crop yields, and contribute to a sustainable agricultural future that benefits both the planet and food supply.

Alan

Series C in 2020
Alan is a digital health insurance platform that aims to simplify and enhance the user experience of health insurance. Established in 2016, it is notable for being the first new independent insurance provider licensed in France since 1986. The company offers a health plan designed to provide an excellent price-quality ratio for both individuals and businesses. Alan's approach focuses on making healthcare more accessible and efficient, positioning itself as a trusted service that prioritizes customer experience. The company has successfully raised over €125 million from prominent investors, further solidifying its innovative presence in the health insurance sector.

Abbisko Therapeutics

Series C in 2020
Abbisko Therapeutics Co. Ltd. discovers, develop, and manufactures immuno-oncology therapies. It offers ABSK011 and ABSK021, which are molecule inhibitors for treating hepatocellular carcinoma; and CSF1R for the treatment of solid tumors. The company also develops therapeutics for the treatment of cancer, tumor, and diabetes, metabolic diseases, liver diseases, viral infections and CNS diseases. The company was founded in 2016 and is based in is based in Shanghai, China.

Kaishu Jianggushi

Series C in 2020
Kaishuo Jianggushi is a children's content provider. Also known as Kaishu Story, the brand is focusing on children’s stories with additional products such as audio series and online parenting courses.

Perfect Day

Series C in 2019
Perfect Day, Inc. is a company that specializes in producing animal-free dairy products, including milk, cheese, yogurt, and ice creams. Founded in 2014 and headquartered in Emeryville, California, the company utilizes yeast fermentation of plant-based sugars to create dairy proteins that are nutritionally identical to those found in cow's milk. This innovative approach allows Perfect Day to offer products that replicate the taste, texture, and nutritional benefits of traditional dairy while avoiding the environmental and ethical concerns associated with animal agriculture. The company's offerings are sustainable, vegan, and free from antibiotics, cholesterol, and lactose, catering to consumers seeking healthier and more compassionate alternatives to conventional dairy.

Provivi

Series C in 2019
Provivi Inc. develops biopesticides for agriculture, commercial, household, and public health pest management. It develops research quantities of carbene/nitrene transferase enzymes that activate diazo and azide compounds to generate iron-carbenoids and iron-nitrenoids through a mode of activation. The company also develops a biocatalysis and fermentation technology, which is based on biocatalysts that enable efficient synthesis of biopesticides. Its technology has applications in industries, such as pharmaceuticals, nutrition, flavors, and fragrances. The company offers its products through distributors worldwide. Provivi Inc. was incorporated in 2012 and is based in Santa Monica, California.

XforcePlus

Series C in 2019
XforcePlus develops enterprise software solutions focused on enhancing supply chain collaboration and invoice management through a cloud-based platform. The company's services include VAT invoicing, electronic billing, payment reconciliation, and comprehensive tax reporting and analysis. By offering tools for efficient invoicing and settlement, XforcePlus enables businesses to improve management of their financial processes, increase tax revenue, and optimize capital utilization. Their solutions are designed to support enterprise clients in achieving greater financial security and operational efficiency.

Avathon

Series C in 2019
SparkCognition, Inc. is a technology company based in Austin, Texas, specializing in artificial intelligence solutions for industrial applications. Established in 2013, the company develops a range of AI-powered products, including SparkPredict, which analyzes sensor data to provide actionable insights and predict equipment failures; DeepArmor, a cybersecurity solution that employs machine learning to detect and prevent malware; and Darwin, which automates the data science process to enhance operational efficiency. Additionally, SparkCognition Government Systems focuses on creating AI systems tailored for government organizations, addressing national security challenges. The company's technologies serve various industries, including oil and gas, aviation, defense, financial services, manufacturing, and utilities, facilitating improved decision-making and enhanced productivity through advanced machine learning capabilities.

TrueLayer

Series C in 2019
TrueLayer Limited is a London-based company that offers a platform for building financial applications. Established in 2016, it provides a toolkit designed to connect to bank data, verify accounts, and access transactions in real-time. TrueLayer's software-as-a-service (SaaS) platform enables the development of various consumer and small-to-medium business applications in sectors such as payments, online lending, personal financial management, robot-advisors, insurance, investment services, peer-to-peer marketplaces, and cryptocurrencies. The company's solutions are utilized by fintech startups, online lenders, and personal finance managers, contributing to the growth of the open banking economy by facilitating the creation of innovative financial services and products.

Pear Therapeutics

Series C in 2019
Pear Therapeutics, Inc. focuses on developing and delivering clinically validated software-based therapeutics aimed at treating behavioral health disorders, including psychiatric and neurologic conditions. The company creates digital therapies for severe conditions such as addiction, schizophrenia, pain, post-traumatic stress disorder, anxiety, depression, and chronic insomnia. Its key products include mobile digital therapies that incentivize patients for completing treatment modules, reSET for substance use disorder, reSET-O for opioid use disorder, and Somryst for insomnia. Additionally, Pear Therapeutics offers PearConnect, a comprehensive patient services center that provides support for patients throughout their treatment journey, connects healthcare providers to resources, and assists insurance companies with claims processing. Founded in 2013, Pear Therapeutics is headquartered in Boston, Massachusetts, with an additional office in San Francisco, California.

Genuity Science

Series C in 2018
Genuity Science is a contract genomics and data-sourcing organization based in Boston, Massachusetts, with additional offices in Dublin, Ireland, and Reykjavik, Iceland. The company collaborates with global biopharma firms to provide comprehensive discovery services that enhance precision health and improve patient outcomes. Its offerings encompass population-scale, disease-specific data sourcing, high-quality sequencing, and advanced statistical analysis, along with software tools for managing large datasets and artificial intelligence applications. Genuity operates state-of-the-art CAP/CLIA genomics laboratories in Woburn, Massachusetts, and Dublin, emphasizing a strong commitment to data stewardship and governance. The company focuses on exploring biological data insights, storage, interpretation, and scalable analytics, particularly in the central nervous system, cardiometabolic, and inflammatory disease sectors.

Blaize

Series C in 2018
Blaize, Inc., founded in 2010 and based in El Dorado Hills, California, specializes in artificial intelligence-enabled edge computing solutions. The company provides a customizable and programmable processor architecture suite, along with a software development platform, aimed at transforming the landscape of AI technology. Through its semiconductor and software offerings, Blaize focuses on delivering innovative solutions tailored to meet the unique demands of various industries.

Orchard Therapeutics

Series C in 2018
Orchard Therapeutics is a biopharmaceutical company based in London, focused on developing innovative gene therapies for serious and life-threatening rare diseases. Operating in the United Kingdom, European Union, and the United States, Orchard employs an autologous ex vivo gene therapy approach to transform patients’ hematopoietic stem cells into gene-modified products for treatment through a single administration. Its portfolio includes Strimvelis, the first approved gene therapy for adenosine deaminase-severe combined immunodeficiency (ADA-SCID), along with several products in clinical development targeting metachromatic leukodystrophy, Wiskott-Aldrich syndrome, X-linked chronic granulomatous disease, and transfusion-dependent beta-thalassemia. The company also has a robust preclinical pipeline addressing various mucopolysaccharidosis types. Orchard collaborates with leading institutions in gene therapy, enhancing its research capabilities and clinical programs. Founded in 2015, Orchard Therapeutics continues to demonstrate a commitment to transforming the lives of patients through its advanced therapies.

Breather

Series C in 2018
Breather Products Inc. is a provider of on-demand private workspaces designed for productivity, allowing clients to reserve and unlock spaces through its web and mobile applications. Founded in 2012 and based in Montreal, Canada, the company has established a network of hundreds of locations across major cities, including New York, San Francisco, Los Angeles, Boston, Chicago, Washington, Toronto, Montreal, and London. Breather offers flexible workspace solutions available by the hour, day, or month, catering to businesses seeking comfortable and private environments. Each space is equipped with technology that facilitates seamless work experiences, enabling users to engage in meetings or video conferences without delay.

Ant Group

Series C in 2018
Ant Group Co., Ltd. is a leading provider of digital payments and financial services in China, primarily known for its flagship platform, Alipay. Founded in 2000 and headquartered in Hangzhou, Ant Group offers a range of financial products, including Yu'e Bao for cash management, Huabei for consumer credit, and Xiang Hu Bao, which provides health coverage for critical illnesses. The company also operates MYbank, an online bank catering to small and micro enterprises, and Zhima Credit, an independent credit assessment service. Ant Group aims to support the digital transformation of the service industry by ensuring equal access to inclusive and sustainable financial services for consumers and small businesses. With a strong emphasis on technology and innovation, the company has played a pivotal role in enhancing trust in online transactions and has expanded its offerings to facilitate digital finance across various sectors.

Ant Group

Series C in 2018
Ant Group Co., Ltd. is a leading provider of digital payments and financial services in China, primarily known for its flagship platform, Alipay. Founded in 2000 and headquartered in Hangzhou, Ant Group offers a range of financial products, including Yu'e Bao for cash management, Huabei for consumer credit, and Xiang Hu Bao, which provides health coverage for critical illnesses. The company also operates MYbank, an online bank catering to small and micro enterprises, and Zhima Credit, an independent credit assessment service. Ant Group aims to support the digital transformation of the service industry by ensuring equal access to inclusive and sustainable financial services for consumers and small businesses. With a strong emphasis on technology and innovation, the company has played a pivotal role in enhancing trust in online transactions and has expanded its offerings to facilitate digital finance across various sectors.

Akili Interactive

Series C in 2018
Akili Interactive Labs, Inc. is a digital medicine company based in Boston, Massachusetts, that develops innovative platform technology to enhance cognitive abilities through video game-like experiences. Incorporated in 2011, the company focuses on creating clinically validated cognitive therapeutics, assessments, and diagnostics that can be prescribed and monitored by physicians remotely. Akili's cognitive engine supports multiple clinical game versions designed for patient engagement and remote data capture. Its proprietary adaptive mechanics allow the software to personalize to each patient's ability level automatically, without requiring clinician input. This approach aims to provide a cost-effective alternative to traditional medical treatments, making advanced cognitive therapies accessible to patients regardless of their location.

SenseTime

Series C in 2018
SenseTime is an artificial intelligence company based in Beijing, China, founded in 2014. It specializes in computer vision and deep learning technologies, offering a range of solutions including face and body analysis, image recognition, and video comprehension. The company develops advanced applications for various sectors, such as smart cities, intelligent automobiles, healthcare, finance, and education. Notably, SenseTime's face recognition technology is widely adopted, serving over 300 companies, including major players like China Mobile and Huawei, with an impressive accuracy rate of one error in 100,000. Additionally, SenseTime is engaged in research and development of AI technologies and provides AI software and hardware products across different industries. Its operations extend beyond China to offices in Japan and Singapore, reflecting its commitment to harnessing AI for diverse applications globally.

Zipline

Series C in 2018
Zipline Inc. is a California-based company that specializes in the design, manufacture, and operation of drones for delivering vital medical supplies, including vaccines, medicines, and blood. Founded in 2011 and headquartered in Half Moon Bay, California, Zipline aims to provide instant access to essential medical products for every individual globally. The company has developed the world's fastest and most reliable delivery drones and operates the largest autonomous logistics network for medical distribution. Its drones are assembled in South San Francisco, while extensive flight testing is conducted in Davis, California. Zipline operates distribution centers worldwide, employing local teams to ensure timely deliveries to hospitals and health centers, particularly in remote areas.

SES

Series C in 2017
SolidEnergy Systems Corp. specializes in the development and manufacturing of rechargeable lithium metal batteries, targeting applications in drones, wearables, smartphones, and electric vehicles. Founded in 2012 and located in Woburn, Massachusetts, the company operates at a pilot scale to produce rechargeable cells for prototype demonstrations and niche aerospace markets. SolidEnergy's core innovation lies in the materials it provides, specifically anodes and electrolytes, which are designed for integration with existing lithium-ion cell manufacturing processes. This compatibility enables the company to scale its production without the need for significant investment in new infrastructure. By supplying these materials to major lithium-ion cell manufacturers, SolidEnergy facilitates the creation of customized battery solutions for a variety of applications, positioning itself for growth in the mainstream consumer electronics and electric vehicle markets.

Tongdun

Series C in 2017
Tongdun Technology is a Chinese fintech start-up specializing in risk control services. The company develops online software solutions for anti-theft and fraud management applications in financial, insurance, payment, online shopping, and social networking companies. The company was founded in 2013 and is based in Hangzhou, China.

Neoway

Series C in 2017
Neoway is a market intelligence and big data analytics company that helps businesses to navigate and extract insights for discovering various market opportunities. It develops and operates SIMM, a subscription based big data analytics platform that allows its users to search detailed data about companies and individuals; export their prospects to the map and distribute the opportunities geographically; control the distribution of opportunities and create multi-platform alerts to their vendors; and map economic groups, and other individual and legal entity relationships, including corporate and administrative structure, suppliers, subsidiaries, and franchises. It serves automotive and transportation, benefits, consumer goods, billing and recovery, construction, oil and gas, health and pharma, technology, and telecom markets, as well as banks, credit cooperatives, and insurance companies and brokers. Jaime de Paula founded Neoway in 2002, with its headquarters in Florianópolis in Brazil. It has additional offices in São Paulo in Brazil and New York City.

ClassPass

Series C in 2017
ClassPass Inc. provides an online fitness class booking service. It offers an online subscription service that provides access to a network of boutique fitness studios and gyms, including cycling, Pilates, yoga, strength training, dance, martial arts, and more. ClassPass Inc. was formerly known as Classtivity Inc. and changed its name to ClassPass Inc. in March 2014. The company was incorporated in 2011 and is based in New York, New York. It has locations in North America, Europe, Asia, and the Oceania.

ClassPass

Series C in 2017
ClassPass Inc. provides an online fitness class booking service. It offers an online subscription service that provides access to a network of boutique fitness studios and gyms, including cycling, Pilates, yoga, strength training, dance, martial arts, and more. ClassPass Inc. was formerly known as Classtivity Inc. and changed its name to ClassPass Inc. in March 2014. The company was incorporated in 2011 and is based in New York, New York. It has locations in North America, Europe, Asia, and the Oceania.

G7

Series C in 2016
G7 has an installation base of 800,000 cargo vehicles throughout China. Through its proprietary hardware devices, the company is able to compile data for logistics companies and drivers on location, route optimization, fuel consumption, and cargo status (temperature, humidity, etc).

ITutorGroup

Series C in 2015
ITutorGroup provides online education platforms for students and business professionals. Its products include VIPABC, TutorABC, VIPABCJr, and TutorABCJr for English-language learning, TutorMing for Mandarin Chinese language learning, and LiveH2H for live translations in multiple languages. Eric Yang, Jerry Huang, and Ming Yang founded ITutorGroup in 1998, with headquarters in Taipei City in Taiwan. It has additional offices in Shanghai in China and Santa Clara in California.

Innovent Biologics

Series C in 2015
Innovent Biologics, Inc. is a prominent biopharmaceutical company based in Suzhou, China, specializing in the discovery, development, manufacture, and commercialization of monoclonal antibody drug candidates. The company focuses on various therapeutic areas, including oncology, ophthalmology, immunology, and metabolic diseases. Its flagship product, Tyvyt (sintilimab), is an anti-PD-1 monoclonal antibody used in treating multiple cancers and is featured on the National Reimbursement Drug List. Innovent has developed several other promising candidates, including biosimilars and bispecific antibodies for conditions such as non-Hodgkin’s lymphoma, autoimmune diseases, and advanced solid tumors. The company has established strategic collaborations with major global pharmaceutical firms, enhancing its research and development capabilities. Founded in 2011, Innovent has a strong management team with extensive experience in biologics, and it continues to expand its portfolio of therapeutic options while maintaining a commitment to innovation in the biopharmaceutical industry.

Chunyu Yisheng

Series C in 2014
Chunyu Yisheng, established in 2011 and headquartered in Beijing, is a mobile application designed to enhance communication between physicians and patients. The app allows doctors to access their patients' medical records and facilitates direct interaction, enabling patients to schedule appointments and communicate with their healthcare providers. Additionally, Chunyu Yisheng offers reservation line treatment services, further supporting users in managing their health. The company focuses on leveraging Internet technology to improve health outcomes and streamline the healthcare experience.

FirstCry

Series C in 2014
FirstCry is an online platform specializing in baby and children's products, offering over 20,000 items from more than 250 renowned international and Indian brands, including Mattel, Pigeon, Pampers, and Disney. Founded in 2010 and headquartered in Pune, India, the company focuses on providing a high-quality online shopping experience with competitive pricing, efficient delivery services, and responsive customer support. In addition to its retail operations, FirstCry is involved in the wholesale sector, promoting and selling baby products and fast-moving consumer goods through various business partners. The company also operates a preschool segment via franchise partnerships across India.

Xiaomi

Series C in 2012
Xiaomi Corporation is an internet company based in Beijing that specializes in the manufacture and distribution of smartphones, consumer electronics, and internet services. Founded in 2010, Xiaomi operates through several segments, including Smartphones, IoT and Lifestyle Products, Internet Services, and Others. The Smartphones segment focuses on selling a range of mobile devices, while the IoT and Lifestyle Products segment includes smart TVs, laptops, AI speakers, and various lifestyle items. The Internet Services segment offers advertising and value-added services, and the Others segment provides hardware repair services. Xiaomi aims to create a comprehensive user experience by integrating user feedback into product design and continuously innovating its offerings. It also engages in wholesale and retail activities, software and hardware development, and operates retail stores and service centers in multiple countries, including India, Russia, and various European nations. The company's commitment to providing high-quality products at competitive prices has fostered a loyal customer base both in China and internationally.

Harbour Networks Holdings

Series C in 2005
Harbour Networks Holdings was acquired by Huawei Technologies Co. Ltd. The company provides Internet protocol-based networking equipment. The company offers Ethernet switches, IP core and edge routers, broadband access equipment, voice over Internet protocol products, optical transport platforms, and networking and services management software, as well as ADSL/VDSL broadband access equipment and NGN integrated access equipment. It serves telecom carriers, corporations, education and government institutions, government agencies, finance, power, and service industries in China, North America, Japan, Hong Kong, and Southeast Asia. The company was founded in 2000 and is based in Beijing, China. As of September 11, 2006, Harbour Networks Holdings Limited operates as a subsidiary of Huawei Technologies Co., Ltd.

BioVex

Series C in 2003
BioVex is a biotechnology company focused on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. Their cancer program, OncoVEXGM-CSF, is a oncolytic vaccine or cancer destroying virus technology that works by replicating and spreading within solid tumors, causing the death of cancer cells while leaving surrounding healthy cells unharmed. The attenuated virus has also been constructed to induce a powerful systemic anti tumor immune response. OncoVEXGM-CSF has now been tested in >110 patients in a broad range of solid tumors including melanoma, head & neck cancer, breast cancer and pancreatic cancer. Both the direct cell killing and systemic immune mediated mechanisms of action of OncoVEX have been clearly validated in the clinic; OncoVEX routinely destroys tumors it is directly injected into and has led to overall disease responses in multiple patients in Phase II testing. Tumors resolved through OncoVEX treatment have not been known to recur.
Semiconductor Manufacturing International Corporation (SMIC) is a semiconductor foundry providing integrated circuit (IC) foundry and technology services at 0.35-micron to 40-nanometer. SMIC develops one-stop turnkey services to meet its customers’ needs. In addition to IC manufacturing, SMIC offers a full range of services that includes design services, mask manufacturing, and testing. SMIC provides integrated circuit (IC) foundry and technology services on process nodes from 0.35 micron to 28 nanometer. Headquartered in Shanghai, China, SMIC has an international manufacturing and service base. In China, SMIC has a 300mm wafer fabrication facility (fab) and a 200mm mega-fab in Shanghai; a 300mm mega-fab and a majority-owned 300mm fab for advanced nodes in Beijing; 200mm fabs in Tianjin and Shenzhen; and a majority-owned joint-venture 300mm bumping facility in Jiangyin; additionally, in Italy SMIC has a majority-owned 200mm fab. Headquartered in Shanghai, China, SMIC has a 300mm wafer fabrication facility (fab) and a 200mm mega-fab in Shanghai, a 300mm mega-fab in Beijing, a 200mm fab in Tianjin, and a 200mm fab project under development in Shenzhen. SMIC also has customer service and marketing offices in the U.S., Europe, Japan, and Taiwan, and a representative office in Hong Kong. SMIC competes with Taiwan Semiconductor Manufacturing Company, Ltd., United Microelectronics Corporation, GlobalFoundries, Fujitsu Limited, Samsung Electronics Co., Ltd., and Toshiba Corporation.

Orqis Medical

Series C in 2003
ORQIS Medical Corporation operates as a medical device company. It develops and sells minimally invasive devices for improving cardiac performance through aortic flow therapy. It offers Cancion System, a heart failure treatment that uses continuous aortic flow augmentation technology to improve symptoms of heart failure and change the underlying course of the disease for patients hospitalized for de-compensated heart failure. The company’s products also include Exeleras System to treat chronic heart failure patients.

Anesiva

Series C in 2002
Anesiva, Inc., a biopharmaceutical company, engages in the development and commercialization of novel therapeutic treatments for pain management worldwide. Its lead product candidate includes Adlea, which completed multiple Phase II and Phase III trials for post-surgical, musculoskeletal, and neuropathic pain. The company was formerly known as AlgoRx Pharmaceuticals, Inc., it changed its name to Anesiva, Inc. in 2006. Anesiva, Inc. was founded in 1999 and is headquartered in South San Francisco, California. On January 15, 2010, Anesiva, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Northern District of California. On June 10, 2014 filed for Chapter 7 bankruptcy.

Savi Technology

Series C in 2001
Savi Technology, Inc. specializes in software solutions designed to enhance the tracking and management of cargo throughout the supply chain. The company offers a range of products, including Savi Insight for predictive and prescriptive analytics, Savi Visibility for real-time operational decision-making, Savi Locate for GPS tracking, and Savi IoT, which integrates RFID technology for efficient data capture and asset management. Founded in 1989 and based in Alexandria, Virginia, Savi serves a diverse clientele, including shippers, government agencies, logistics providers, and technology firms. The company's innovative applications leverage big data analytics and machine learning to improve in-transit visibility, reduce disruptions, enhance delivery performance, and lower logistics costs for over 1,000 organizations worldwide.

Paypal

Series C in 2000
PayPal is a leading provider of electronic payment solutions, empowering individuals and businesses to engage in secure transactions worldwide. With a commitment to democratizing financial services, PayPal's platform supports 426 million active accounts and facilitates payments in over 200 markets. Users can connect and transact online, via mobile devices, or in person, with the ability to manage funds in more than 100 currencies. The company also owns popular services such as Venmo and Braintree, enhancing its offerings for consumer and merchant transactions. Established as a separate entity from eBay in 2015, PayPal continues to innovate through strategic partnerships and investments, including its venture capital arm, PayPal Ventures, which focuses on fostering entrepreneurship and advancing financial technology solutions.

DoveBid

Series C in 2000
DoveBid, Inc. specializes in providing capital asset auction, valuation, and management services for corporations, government agencies, and financial institutions globally. The firm offers a range of asset disposition solutions, including live Webcast auctions, online auctions, sealed bid internet sales, and private treaty internet sales. Additionally, DoveBid provides appraisal and surplus asset management services, along with support for leasing, shipping, and transactions. The company serves clients across various sectors, such as biotechnology, pharmaceuticals, chemicals, construction, and telecommunications, among others. Founded in 1937 and originally known as Dove Mercantile Co., it underwent several name changes before becoming DoveBid, Inc. It is headquartered in Culver City, California.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.